Kathmere Capital Management LLC Buys New Shares in Agilent Technologies, Inc. (NYSE:A)

Kathmere Capital Management LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,669 shares of the medical research company’s stock, valued at approximately $243,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Ballentine Partners LLC boosted its holdings in shares of Agilent Technologies by 2.5% during the first quarter. Ballentine Partners LLC now owns 2,963 shares of the medical research company’s stock worth $431,000 after acquiring an additional 73 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Agilent Technologies by 3.2% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,421 shares of the medical research company’s stock worth $337,000 after buying an additional 75 shares in the last quarter. Carmel Capital Partners LLC increased its holdings in Agilent Technologies by 1.2% in the fourth quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock valued at $933,000 after purchasing an additional 78 shares during the period. Monumental Financial Group Inc. increased its holdings in Agilent Technologies by 0.9% in the fourth quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company’s stock valued at $1,320,000 after purchasing an additional 89 shares during the period. Finally, Kepos Capital LP boosted its position in Agilent Technologies by 3.5% during the third quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock valued at $310,000 after acquiring an additional 93 shares during the last quarter.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the transaction, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the transaction, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Stock Performance

NYSE A opened at $129.63 on Friday. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The company has a market capitalization of $37.82 billion, a P/E ratio of 30.65, a P/E/G ratio of 4.44 and a beta of 1.07. The company has a fifty day moving average of $139.56 and a 200-day moving average of $138.40.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The company had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm’s revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.27 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be given a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, July 2nd. Agilent Technologies’s payout ratio is 22.22%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on A shares. Bank of America increased their price objective on shares of Agilent Technologies from $134.00 to $140.00 and gave the stock a “neutral” rating in a research report on Tuesday. TD Cowen dropped their price target on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating on the stock in a research report on Thursday, May 30th. Stifel Nicolaus dropped their price target on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a research report on Thursday, May 30th. Oppenheimer raised their price target on shares of Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $136.88.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.